SMS Opt-In Sample (Screening Form Excerpt)

SMS Opt-In Sample

Last updated: April 2026

The Pain Research and Intervention Center of Excellence (PRICE) at the University of Florida enrolls participants into IRB-approved clinical research studies. As part of each study’s telephone or in-person screening interview, study staff offer the participant the option to receive SMS appointment reminders. This page publishes a redacted excerpt of the IRB-approved screening form and the verbatim disclosure script so that the opt-in process is publicly verifiable.

Note: This page is provided for transparency and regulatory compliance. Participants are never asked to opt in via this website. Opt-in occurs only during a live screening conversation between the participant and trained study staff, after which the participant’s response is recorded on the screening form by the coordinator.

1. Disclosure script (read aloud by study staff)

During screening, the study coordinator reads the following script to every eligible participant before requesting a mobile phone number:

“As part of this study, we can send you text message reminders before each of your scheduled study visits. The reminders will come from the University of Florida PRICE study team at (352) 278-9116. You would typically receive up to two messages per visit — a reminder, and where applicable a confirmation follow-up. Message and data rates may apply depending on your mobile plan. You can reply STOP at any time to stop the messages, or reply HELP for assistance. Participating in the reminders is voluntary and is not required to take part in the study. Would you like to receive these text message reminders at a mobile number you provide?”

The participant’s verbal response (yes / no / declined to answer) and, if applicable, the mobile phone number are recorded on the IRB-approved screening form by the study coordinator.

2. Redacted screening-form excerpt

Below is a redacted excerpt of the section of the PRICE screening form that documents SMS opt-in. Full screening forms are IRB-protected and not published.

SECTION [X]. SMS APPOINTMENT REMINDERS — OPT-IN

Coordinator: Read the SMS disclosure script above to the participant.
              Record the participant's response below.

  [ ]  Yes — participant consents to receive SMS reminders
  [ ]  No  — participant declines SMS reminders
  [ ]  Declined to answer / not eligible

If YES:
  Mobile number provided:  (___) ___ - ________
  Carrier (if known):      _____________________
  Preferred time window:   _____________________

Coordinator initials: _______      Date: ____ / ____ / ______

Only participants who select “Yes” and provide a mobile number are enrolled in the SMS reminder program. Their response, the coordinator’s initials, and the date of opt-in are retained with the study’s regulatory records.

3. What happens after opt-in

Enrolled participants receive SMS messages from (352) 278-9116 only, containing appointment reminders for their scheduled study visits. Messages will always:

  • Identify the sender as the UF PRICE study
  • Include STOP and HELP instructions
  • Never include marketing, promotional, or third-party content

See the SMS Terms and Conditions and SMS Privacy Notice for the full program terms.

4. How participants can revoke consent

At any time after opt-in, a participant may stop messages by:

  • Replying STOP to any message received from (352) 278-9116
  • Contacting the study team at price-ctsi@ufl.edu or (352) 273-7620

Revoking SMS consent does not affect the participant’s eligibility or continued participation in the research study.

5. Contact

Pain Research and Intervention Center of Excellence

University of Florida

2004 Mowry Road, Gainesville, FL 32610

Phone: (352) 273-7620

Email: price-ctsi@ufl.edu

For questions about your rights as a research participant, contact the University of Florida Institutional Review Board at (352) 273-9600 or irb2@ufl.edu.